Furthermore, LDHA abrogation has been shown to reduce tumorigenesis and tumor growth and decrease the survival and proliferation of TICs in a novel inducible NSCLC mouse models in the context of KRAS or EGFR mutations [26]. The gene discussed is LDHA; the disease is non-small cell lung carcinoma.